Bristol Myers Squibb can navigate the dreaded patent cliff while maintaining modest dividend growth. Medtronic's strong, innovative business helps support its impressive dividend program. Considering ...

The NICE committee concluded that it needed additional data on various survival endpoints and further cost-effectiveness analyses.

The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...

McCarter Theatre Center has announced its 2026-27 Theater Series, featuring five productions spanning Shakespearean villainy, ...

(NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced two advancements in scale and depth of the Alliance ...

LCGC International's "LC Troubleshooting" column editor Dwight Stoll and colleagues pay tribute to the late Peter Carr, an ...

Prothena Corporation plc kept at Hold after mixed phase 2 results; key phase 3 readouts expected 2029. Click for this updated ...

Poplar Therapeutics is seeking a “step change” in the treatment of food allergy and other atopic conditions, with $95 million ...

In honor of Brain Injury Awareness Month, the West Virginia Department of Human Services (DoHS), Bureau for Medical Services ...

“Incorporating ctDNA into the decision-making process helps refine who can safely keep their bladder,” Ghatalia, associate professor, Department of Hematology/Oncology, at Fox Chase Cancer Center in ...

A multicenter research effort yielded findings that may allow for more effective and personalized treatment of an underrecognized but serious blood disorder.Extended follow-up of individuals with ...

By M. Marin NASDAQ:ORMP READ THE FULL ORMP RESEARCH REPORT Transaction enables exposure to both oral drug delivery program & medical device businesses Oramed Pharmaceuticals (NASDAQ:ORMP) recently ...